📢 Start of our new series for unlocking the power of statistics 💪

💡 Why does statistical knowledge matter for Market Access?

HTA decisions rely on solid evidence, but statistical methods can feel complex and confusing. Understanding the essentials helps you to navigate uncertainty, strengthen arguments, and drive better decision-making.

🏗️Our goal: Building your statistical confidence
 

This series is designed to make key statistical concepts clear, practical, and relevant for Market Access manager.

✅ Interpreting and leveraging clinical trial data effectively

✅ Communicating statistical results with clarity and confidence

✅ Identifying relevant arguments for benefit dossier and negotiations
 

🔜 What’s coming up?

▫️ Beyond p-values: Why statistical significance isn’t enough for HTA decisions

▫️ Indirect comparisons: Making the most of indirect comparisons when head-to-head trials are missing

▫️ Propensity Score Matching: Creating comparable treatment groups when randomization isn’t possible

 

➡️ Comment below on any additional statistical topics you would like to build confidence in and follow the statistical experts of Ecker + Ecker GmbH as they discover statistical concepts together with you 🚀